Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,522
archived clinical trials in
Chronic Pain

Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
Illinois Neuro Spine Center
299
mi
from 43215
Ogden, IL
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
Updated: 1/1/1970
Illinois Neuro Spine Center
299
mi
from 43215
Ogden, IL
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
St. Joseph's Medical Center- CA
2045
mi
from 43215
Stockton, CA
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
Updated: 1/1/1970
St. Joseph's Medical Center- CA
2045
mi
from 43215
Stockton, CA
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
The Boston Spine Group
643
mi
from 43215
Boston, MA
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
Updated: 1/1/1970
The Boston Spine Group
643
mi
from 43215
Boston, MA
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
New England Neuro Assoc.
563
mi
from 43215
Springfield, MA
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
Updated: 1/1/1970
New England Neuro Assoc.
563
mi
from 43215
Springfield, MA
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
Columbia Orthopedic Group
499
mi
from 43215
Columbia, MO
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
Updated: 1/1/1970
Columbia Orthopedic Group
499
mi
from 43215
Columbia, MO
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
Orthopedic Spine Care of Long Island
510
mi
from 43215
Huntington Station, NY
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
Updated: 1/1/1970
Orthopedic Spine Care of Long Island
510
mi
from 43215
Huntington Station, NY
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
Buffalo Spine Surgery
314
mi
from 43215
Lockport, NY
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
Updated: 1/1/1970
Buffalo Spine Surgery
314
mi
from 43215
Lockport, NY
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
Carolina NeuroSurgery & Spine Associates
349
mi
from 43215
Charlotte, NC
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
Updated: 1/1/1970
Carolina NeuroSurgery & Spine Associates
349
mi
from 43215
Charlotte, NC
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
NeuroSpine Center of Wisconsin
408
mi
from 43215
Appleton, WI
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
Updated: 1/1/1970
NeuroSpine Center of Wisconsin
408
mi
from 43215
Appleton, WI
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
Milwaukee Spinal Specialists
331
mi
from 43215
Milwaukee, WI
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
Status: Archived
Updated: 1/1/1970
Milwaukee Spinal Specialists
331
mi
from 43215
Milwaukee, WI
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Arkansas Children's Hospital
622
mi
from 43215
Little Rock, AR
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Arkansas Children's Hospital
622
mi
from 43215
Little Rock, AR
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Stanford university Hospital and Clinics
2100
mi
from 43215
Stanford, CA
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Stanford university Hospital and Clinics
2100
mi
from 43215
Stanford, CA
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Children's Medical Center of Dallas
911
mi
from 43215
Dallas, TX
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Children's Medical Center of Dallas
911
mi
from 43215
Dallas, TX
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Connecticut Children's Medical Center
553
mi
from 43215
Hartford, CT
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Connecticut Children's Medical Center
553
mi
from 43215
Hartford, CT
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Children's Nutrition Research Center, Baylor College of Medicine
995
mi
from 43215
Houston, TX
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Children's Nutrition Research Center, Baylor College of Medicine
995
mi
from 43215
Houston, TX
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Florida Institute of Medical Research
678
mi
from 43215
Jacksonville, FL
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Florida Institute of Medical Research
678
mi
from 43215
Jacksonville, FL
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Tukoi Clinical Research
957
mi
from 43215
Miami, FL
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Tukoi Clinical Research
957
mi
from 43215
Miami, FL
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
St. Joseph's Hospital
163
mi
from 43215
Ann Arbor, MI
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
St. Joseph's Hospital
163
mi
from 43215
Ann Arbor, MI
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Taylor Research LLC
425
mi
from 43215
Marietta, GA
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Taylor Research LLC
425
mi
from 43215
Marietta, GA
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Rehabilitation Associates of Indiana
161
mi
from 43215
Indianapolis, IN
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Rehabilitation Associates of Indiana
161
mi
from 43215
Indianapolis, IN
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
University of Louisville Hospital
188
mi
from 43215
Louisville, KY
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
University of Louisville Hospital
188
mi
from 43215
Louisville, KY
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
The Center for Clinical Research
307
mi
from 43215
Winston-Salem, NC
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
The Center for Clinical Research
307
mi
from 43215
Winston-Salem, NC
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Penn State Milton S. Hershey Medical Center
337
mi
from 43215
Hershey, PA
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.
Status: Archived
Updated: 1/1/1970
Penn State Milton S. Hershey Medical Center
337
mi
from 43215
Hershey, PA
Sedation and Pain (The Effect of IV Sedation on Pain Perception)
Sedation and Pain (The Effect of IV Sedation on Pain Perception)
Status: Archived
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Sedation and Pain (The Effect of IV Sedation on Pain Perception)
Sedation and Pain (The Effect of IV Sedation on Pain Perception)
Status: Archived
Updated: 1/1/1970
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Evaluating a Chronic Pain Treatment Program
Evaluating Outcomes and Response Profiles of a Psychological Treatment for People With Chronic Pain
Status: Archived
St. John Providence Health System
173
mi
from 43215
Southfield, MI
Evaluating a Chronic Pain Treatment Program
Evaluating Outcomes and Response Profiles of a Psychological Treatment for People With Chronic Pain
Status: Archived
Updated: 1/1/1970
St. John Providence Health System
173
mi
from 43215
Southfield, MI
The Predictors and Patient Versus Parental Perceptions of Health-Related Quality of Life in Pediatric Chronic Pain
The Predictors and Patient Versus Parental Perceptions of Health-Related Quality of Life in Pediatric Chronic Pain
Status: Archived
Children's Hospital of New York - Columbia University Medical Center
481
mi
from 43215
New York, NY
The Predictors and Patient Versus Parental Perceptions of Health-Related Quality of Life in Pediatric Chronic Pain
The Predictors and Patient Versus Parental Perceptions of Health-Related Quality of Life in Pediatric Chronic Pain
Status: Archived
Updated: 1/1/1970
Children's Hospital of New York - Columbia University Medical Center
481
mi
from 43215
New York, NY
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery
The Efficacy and Safety of Mapracorat Ophthalmic Suspension, 3% in Subjects for the Treatment of Ocular Inflammation Following Cataract Surgery
Status: Archived
Bausch & Lomb
358
mi
from 43215
Rochester, NY
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery
The Efficacy and Safety of Mapracorat Ophthalmic Suspension, 3% in Subjects for the Treatment of Ocular Inflammation Following Cataract Surgery
Status: Archived
Updated: 1/1/1970
Bausch & Lomb
358
mi
from 43215
Rochester, NY
A Trial of 2% Lidocaine Gel for Intrauterine Device (IUD) Insertion
A Randomized Controlled Trial of 2% Lidocaine Gel for IUD Insertion
Status: Archived
Women's Primary Care Center/Women and Infants' Hospital
619
mi
from 43215
Providence, RI
A Trial of 2% Lidocaine Gel for Intrauterine Device (IUD) Insertion
A Randomized Controlled Trial of 2% Lidocaine Gel for IUD Insertion
Status: Archived
Updated: 1/1/1970
Women's Primary Care Center/Women and Infants' Hospital
619
mi
from 43215
Providence, RI
A Trial of 2% Lidocaine Gel for Intrauterine Device (IUD) Insertion
A Randomized Controlled Trial of 2% Lidocaine Gel for IUD Insertion
Status: Archived
Brown University, Women & Infants Hospital of Rhode Island
619
mi
from 43215
Providence, RI
A Trial of 2% Lidocaine Gel for Intrauterine Device (IUD) Insertion
A Randomized Controlled Trial of 2% Lidocaine Gel for IUD Insertion
Status: Archived
Updated: 1/1/1970
Brown University, Women & Infants Hospital of Rhode Island
619
mi
from 43215
Providence, RI
MC5-A Scrambler Therapy in Reducing Peripheral Neuropathy Caused by Chemotherapy
Scrambler Therapy for the Treatment of Chemotherapy Induced Peripheral Neuropathy: An Evaluation of a Sham Procedure and Phase II Trial
Status: Archived
Mayo Clinic Rochester
559
mi
from 43215
Rochester, MN
MC5-A Scrambler Therapy in Reducing Peripheral Neuropathy Caused by Chemotherapy
Scrambler Therapy for the Treatment of Chemotherapy Induced Peripheral Neuropathy: An Evaluation of a Sham Procedure and Phase II Trial
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
559
mi
from 43215
Rochester, MN
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
Status: Archived
Caritas St. Elizabeth Medical Center
638
mi
from 43215
Brighton, MA
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
Status: Archived
Updated: 1/1/1970
Caritas St. Elizabeth Medical Center
638
mi
from 43215
Brighton, MA
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
Status: Archived
Furiex research site
2002
mi
from 43215
West Lake Village, CA
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
Status: Archived
Updated: 1/1/1970
Furiex research site
2002
mi
from 43215
West Lake Village, CA
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
Status: Archived
Maine Research Associates
714
mi
from 43215
Auburn, ME
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
Status: Archived
Updated: 1/1/1970
Maine Research Associates
714
mi
from 43215
Auburn, ME
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
Status: Archived
Connecticut Gastroenterology Institute
539
mi
from 43215
Bristol, CT
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
Status: Archived
Updated: 1/1/1970
Connecticut Gastroenterology Institute
539
mi
from 43215
Bristol, CT
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
Status: Archived
Furiex research site
401
mi
from 43215
St. Louis, MO
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
Status: Archived
Updated: 1/1/1970
Furiex research site
401
mi
from 43215
St. Louis, MO
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
Status: Archived
Binghamton Gastroenterology
398
mi
from 43215
Binghamton, NY
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
Status: Archived
Updated: 1/1/1970
Binghamton Gastroenterology
398
mi
from 43215
Binghamton, NY
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
Status: Archived
Furiex research site
89
mi
from 43215
Cincinnati, OH
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
Status: Archived
Updated: 1/1/1970
Furiex research site
89
mi
from 43215
Cincinnati, OH
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
Status: Archived
Furiex research site
247
mi
from 43215
Altoona, PA
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
Status: Archived
Updated: 1/1/1970
Furiex research site
247
mi
from 43215
Altoona, PA
A Comparison of Postoperative Tramadol Versus Acetaminophen With Codeine in Children Undergoing Tonsillectomy
A Comparison of Postoperative Tramadol Versus Acetaminophen With Codeine in Children Undergoing Tonsillectomy
Status: Archived
Children's Hospital/USC School of Medicine
1973
mi
from 43215
Los Angeles, CA
A Comparison of Postoperative Tramadol Versus Acetaminophen With Codeine in Children Undergoing Tonsillectomy
A Comparison of Postoperative Tramadol Versus Acetaminophen With Codeine in Children Undergoing Tonsillectomy
Status: Archived
Updated: 1/1/1970
Children's Hospital/USC School of Medicine
1973
mi
from 43215
Los Angeles, CA
Proparacaine and Mydriatic Eye Drops
Randomized Control Trial of the Effects of Proparacaine on the Pain Response to Mydriatic Eye Drops
Status: Archived
University of Pennsylvania, Pennsylvania Hospital Department of Neurology , 330 South 9Th Street
416
mi
from 43215
Philadelphia, PA
Proparacaine and Mydriatic Eye Drops
Randomized Control Trial of the Effects of Proparacaine on the Pain Response to Mydriatic Eye Drops
Status: Archived
Updated: 1/1/1970
University of Pennsylvania, Pennsylvania Hospital Department of Neurology , 330 South 9Th Street
416
mi
from 43215
Philadelphia, PA
J-Tip® Jet Injection of 1% Buffered Lidocaine or Saline Versus 4% Lidocaine Cream Before Venipuncture or IV Insertion
Comparison of J-Tip® Jet Injection of 1% Buffered Lidocaine, 4% Lidocaine Topical Cream, and J-Tip® Jet Injection of Placebo Prior to Venipuncture and Peripheral Intravenous Catheter Insertion in a Pediatric Emergency Department
Status: Archived
Children's Hospital Central California
1995
mi
from 43215
Madera, CA
J-Tip® Jet Injection of 1% Buffered Lidocaine or Saline Versus 4% Lidocaine Cream Before Venipuncture or IV Insertion
Comparison of J-Tip® Jet Injection of 1% Buffered Lidocaine, 4% Lidocaine Topical Cream, and J-Tip® Jet Injection of Placebo Prior to Venipuncture and Peripheral Intravenous Catheter Insertion in a Pediatric Emergency Department
Status: Archived
Updated: 1/1/1970
Children's Hospital Central California
1995
mi
from 43215
Madera, CA
A Patient-Controlled Cognitive-Behavioral Intervention for Cancer Symptoms
A Patient-Controlled Cognitive-Behavioral Intervention for Cancer Symptoms
Status: Archived
University of Wisconsin-Madison, Department of Dermatology
393
mi
from 43215
Madison, WI
A Patient-Controlled Cognitive-Behavioral Intervention for Cancer Symptoms
A Patient-Controlled Cognitive-Behavioral Intervention for Cancer Symptoms
Status: Archived
Updated: 1/1/1970
University of Wisconsin-Madison, Department of Dermatology
393
mi
from 43215
Madison, WI
Neurofeedback Treatment of Pain in Persons With Spinal Cord Injury (SCI)
Neurofeedback Treatment of Pain in Persons With SCI: Phase 1
Status: Archived
University of Washington
1982
mi
from 43215
Seattle, WA
Neurofeedback Treatment of Pain in Persons With Spinal Cord Injury (SCI)
Neurofeedback Treatment of Pain in Persons With SCI: Phase 1
Status: Archived
Updated: 1/1/1970
University of Washington
1982
mi
from 43215
Seattle, WA
Neurofeedback Treatment of Pain in Persons With Spinal Cord Injury (SCI)
Neurofeedback Treatment of Pain in Persons With SCI: Phase 2
Status: Archived
University of Washington
1982
mi
from 43215
Seattle, WA
Neurofeedback Treatment of Pain in Persons With Spinal Cord Injury (SCI)
Neurofeedback Treatment of Pain in Persons With SCI: Phase 2
Status: Archived
Updated: 1/1/1970
University of Washington
1982
mi
from 43215
Seattle, WA
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
The Use of Glutathione (GSH) for Prevention of Paclitaxel/Carboplatin (TAXOL/CBDCA) Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo Controlled Study
Status: Archived
Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
3032
mi
from 43215
Fairbanks, AK
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
The Use of Glutathione (GSH) for Prevention of Paclitaxel/Carboplatin (TAXOL/CBDCA) Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo Controlled Study
Status: Archived
Updated: 1/1/1970
Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
3032
mi
from 43215
Fairbanks, AK
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
The Use of Glutathione (GSH) for Prevention of Paclitaxel/Carboplatin (TAXOL/CBDCA) Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo Controlled Study
Status: Archived
Mayo Clinic Scottsdale
1645
mi
from 43215
Scottsdale, AZ
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
The Use of Glutathione (GSH) for Prevention of Paclitaxel/Carboplatin (TAXOL/CBDCA) Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo Controlled Study
Status: Archived
Updated: 1/1/1970
Mayo Clinic Scottsdale
1645
mi
from 43215
Scottsdale, AZ
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
The Use of Glutathione (GSH) for Prevention of Paclitaxel/Carboplatin (TAXOL/CBDCA) Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo Controlled Study
Status: Archived
North Bay Cancer Center
2077
mi
from 43215
Fairfield, CA
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
The Use of Glutathione (GSH) for Prevention of Paclitaxel/Carboplatin (TAXOL/CBDCA) Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo Controlled Study
Status: Archived
Updated: 1/1/1970
North Bay Cancer Center
2077
mi
from 43215
Fairfield, CA
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
The Use of Glutathione (GSH) for Prevention of Paclitaxel/Carboplatin (TAXOL/CBDCA) Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo Controlled Study
Status: Archived
Aurora Presbyterian Hospital
1154
mi
from 43215
Aurora, CO
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
The Use of Glutathione (GSH) for Prevention of Paclitaxel/Carboplatin (TAXOL/CBDCA) Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo Controlled Study
Status: Archived
Updated: 1/1/1970
Aurora Presbyterian Hospital
1154
mi
from 43215
Aurora, CO
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
The Use of Glutathione (GSH) for Prevention of Paclitaxel/Carboplatin (TAXOL/CBDCA) Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo Controlled Study
Status: Archived
Boulder Community Hospital
1171
mi
from 43215
Boulder, CO
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
The Use of Glutathione (GSH) for Prevention of Paclitaxel/Carboplatin (TAXOL/CBDCA) Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo Controlled Study
Status: Archived
Updated: 1/1/1970
Boulder Community Hospital
1171
mi
from 43215
Boulder, CO
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
The Use of Glutathione (GSH) for Prevention of Paclitaxel/Carboplatin (TAXOL/CBDCA) Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo Controlled Study
Status: Archived
Penrose Hospital
1172
mi
from 43215
Colorado Springs, CO
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
The Use of Glutathione (GSH) for Prevention of Paclitaxel/Carboplatin (TAXOL/CBDCA) Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo Controlled Study
Status: Archived
Updated: 1/1/1970
Penrose Hospital
1172
mi
from 43215
Colorado Springs, CO